ArticlesRisk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
Introduction
Venous thromboembolism is a major health problem,1 for which pulmonary embolism is a potentially lethal complication. Pulmonary embolism is a common cardiovascular and cardiopulmonary illness with a yearly incidence in the USA of more than one case per 1000 people and a mortality rate of more than 15% in the first 3 months after diagnosis,2 which is similar to that for acute myocardial infarction.3 Inflammation and venous thromboembolism are linked,4 with inflammation driving venous thrombosis. Inflammation modulates thrombotic responses by upregulating procoagulants, downregulating anticoagulants, and suppressing fibrinolysis.4 Therefore, autoimmune disorders such as inflammatory bowel disease,5, 6, 7, 8 Behçet's syndrome,9 rheumatoid arthritis,10 celiac disease,11 type-1 diabetes mellitus,12 systemic lupus erythematosus,13 hyperthyroidism,14 and Wegener's granulomatosis15 have been associated with an increased risk of venous thromboembolism. Autoimmune disorders are additional risk factors for venous thromboembolism in patients admitted to hospital;16 however, rheumatic disorders were not significant risk factors in the Medinox study.17
Previous studies of the association between venous thromboembolism and autoimmune diseases have often been small and done mostly in individual autoimmune diseases. We postulated that the inflammation associated with autoimmune disorders could affect the risk of pulmonary embolism in 33 autoimmmune diseases. We evaluated the risk of hospital admission with pulmonary embolism in all patients previously admitted with an autoimmune disorder in Sweden.
Section snippets
Data sources
We retrieved data from the MigMed2 database. This database contains information about all registered residents of Sweden for age, sex, occupation, region of residence, hospital diagnoses, dates of hospital admissions in Sweden (1964–2008), country of birth, parents’ country of birth, date of emigration, and date and cause of death. The database was constructed with several national Swedish data registers,18 including, but not limited to, the Swedish National Population and Housing Census
Results
Table 1 shows the number of patients in Sweden who were admitted to hospital with any of the 33 most common autoimmune disorders during the study period. 535 538 patients were admitted with an autoimmune disorder (table 1). The three most common autoimmune disorders were rheumatoid arthritis, Hashimoto's thyroiditis, and Graves’ disease (table 1). For the calculations of SIRs, we exluded 20 401 autoimmune patients because of previous admission for venous thromboembolism or coexisting venous
Discussion
Our results show that autoimmune disorders affect the risk of hospital admission for pulmonary embolism in men and women of all ages. The risk of pulmonary embolism during the first year after admission with an autoimmune disorder was high, and although it decreased over time, the overall risk remained for up to 10 years. Our results are consistent with previous findings linking inflammatory bowel disease,5, 6, 7, 8 Behçet's disease,9 rheumatoid arthritis,10 coeliac disease,11 type-1 diabetes
References (29)
- et al.
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
Lancet
(1999) - et al.
Diabetes mellitus and risk of venous thromboembolism
Am J Med Sci
(2009) - et al.
Deep vein thrombosis
Lancet
(2005) - et al.
Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men
J Thromb Haemost
(2008) The Epidemiology of venous thromboembolism
Circulation
(2003)- et al.
Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis
Circulation
(2003) - et al.
Inflammation, innate immunity and blood coagulation
Hamostaseologie
(2010) - et al.
Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events
World J Gastroenterol
(2009) - et al.
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
Gut
(2004) - et al.
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study
Thromb Haemost
(2001)
Inflammatory bowel disease promotes venous thrombosis earlier in life
Scand J Gastroenterol
Behçet's syndrome
Curr Rheumatol Rep
Risk of venous thromboembolism with rheumatoid arthritis
Thromb Haemost
Risk of thromboembolism in 14 000 individuals with coeliac disease
Br J Haematol
Cited by (279)
Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study
2024, European Journal of Internal MedicineRisk of venous thromboembolism in autoimmune diseases: A comprehensive review
2023, Autoimmunity ReviewsInflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
2023, JACC: Basic to Translational ScienceAutoimmune disease and risk of postpartum venous thromboembolism
2023, Research and Practice in Thrombosis and HaemostasisRecurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study
2022, Research and Practice in Thrombosis and HaemostasisIncidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease
2022, Thrombosis Research